Jody Dushay, M.D., is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center
Improving Mood and Reducing Symptoms of Depression: Acetyl L-carnitine has shown promise in improving mood and reducing symptoms of depression
Retatrutide works as a triple receptor agonist, targeting three key hormonal pathways simultaneously: [1] [4] GLP-1 (glucagon-like peptide-1): Is thought to reduce appetite and slow gastric emptying GIP (glucose-dependent insulinotropic polypeptide): Is thought to enhance insulin secretion and may influence fat metabolism, though human evidence remains limited Glucagon receptor: Has been observed in early studies to increase energy expenditure and promote fat breakdown, though the clinical significance in humans is still being established This triple-action mechanism distinguishes retatrutide from currently approved dual or single agonists
By activating neurons that suppress appetite and blocking those that stimulate it, these medications help curb the desire to eat
A phase 3, randomized, double-blind CVOT, SURPASS-CVOT, is currently ongoing and aiming to assess tirzepatide vs
Im also appreciative for your reading and subscribing to Ground Truths